Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 09 2022
Historique:
received: 11 02 2022
accepted: 16 08 2022
entrez: 6 9 2022
pubmed: 7 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

SIVmac239 infection of macaques is a favored model of human HIV infection. However, the SIVmac239 envelope (Env) trimer structure, glycan occupancy, and the targets and ability of neutralizing antibodies (nAbs) to protect against SIVmac239 remain unknown. Here, we report the isolation of SIVmac239 nAbs that recognize a glycan hole and the V1/V4 loop. A high-resolution structure of a SIVmac239 Env trimer-nAb complex shows many similarities to HIV and SIVcpz Envs, but with distinct V4 features and an extended V1 loop. Moreover, SIVmac239 Env has a higher glycan shield density than HIV Env that may contribute to poor or delayed nAb responses in SIVmac239-infected macaques. Passive transfer of a nAb protects macaques from repeated intravenous SIVmac239 challenge at serum titers comparable to those described for protection of humans against HIV infection. Our results provide structural insights for vaccine design and shed light on antibody-mediated protection in the SIV model.

Identifiants

pubmed: 36068229
doi: 10.1038/s41467-022-32783-2
pii: 10.1038/s41467-022-32783-2
pmc: PMC9446601
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antibodies, Viral 0
Polysaccharides 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5236

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI144462
Pays : United States
Organisme : NIAID NIH HHS
ID : R61 AI161818
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201500003I
Pays : United States
Organisme : NIH HHS
ID : P51 OD011106
Pays : United States
Organisme : NCI NIH HHS
ID : 75N91019D00024
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI052056
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

iScience. 2020 Nov 20;23(12):101836
pubmed: 33319171
Acta Crystallogr D Struct Biol. 2018 Apr 1;74(Pt 4):256-263
pubmed: 29652253
Nat Med. 2020 Jun;26(6):932-940
pubmed: 32393800
Structure. 2019 Feb 5;27(2):344-358.e3
pubmed: 30449687
N Engl J Med. 2013 Nov 28;369(22):2083-92
pubmed: 24099601
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
J Virol. 2006 Mar;80(5):2515-28
pubmed: 16474158
Mol Ther Methods Clin Dev. 2020 Feb 13;16:225-237
pubmed: 32083148
J Virol. 2017 Sep 27;91(20):
pubmed: 28768869
Nat Struct Mol Biol. 2015 Nov;22(11):833-4
pubmed: 26581513
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4144-9
pubmed: 12644702
Sci Transl Med. 2012 Jul 11;4(142):142ra96
pubmed: 22786681
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Nature. 2014 Jan 23;505(7484):502-8
pubmed: 24352234
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
J Virol. 1998 Jul;72(7):5399-407
pubmed: 9620994
Elife. 2016 Sep 26;5:
pubmed: 27669148
Nature. 2013 Oct 3;502(7469):100-4
pubmed: 24025770
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Biopolymers. 2012 Sep;97(9):742-60
pubmed: 22696409
Nucleic Acids Res. 2016 Jul 8;44(W1):W474-8
pubmed: 27131379
Nature. 2012 Jan 04;482(7383):89-93
pubmed: 22217938
Immunity. 2019 Oct 15;51(4):724-734.e4
pubmed: 31586542
Nat Protoc. 2013 Oct;8(10):1907-15
pubmed: 24030440
AIDS. 2016 Oct 23;30(16):2427-2438
pubmed: 27428745
Nat Methods. 2015 Oct;12(10):943-6
pubmed: 26280328
Nat Commun. 2015 Apr 10;6:6565
pubmed: 25858157
J Exp Med. 2008 Oct 27;205(11):2537-50
pubmed: 18838548
PLoS Pathog. 2016 Apr 11;12(4):e1005537
pubmed: 27064278
PLoS Pathog. 2015 Aug 06;11(8):e1005090
pubmed: 26248318
Cell Host Microbe. 2014 Sep 10;16(3):412-8
pubmed: 25211081
Cell Host Microbe. 2019 Sep 11;26(3):336-346.e3
pubmed: 31513771
Front Immunol. 2014 May 08;5:202
pubmed: 24847327
Sci Transl Med. 2014 Jul 2;6(243):243ra88
pubmed: 24990883
Science. 1985 Jun 7;228(4704):1201-4
pubmed: 3159089
J Struct Biol. 2021 Jun;213(2):107702
pubmed: 33582281
J Immunol. 1996 Dec 15;157(12):5528-35
pubmed: 8955203
J Virol. 2006 Jun;80(12):5875-85
pubmed: 16731926
AIDS Res Hum Retroviruses. 1994 Feb;10(2):213-20
pubmed: 8198874
J Virol. 2015 Aug;89(16):8130-51
pubmed: 26018167
Nat Immunol. 2014 Apr;15(4):319-22
pubmed: 24646598
J Struct Biol. 2010 Jun;170(3):427-38
pubmed: 20338243
J Am Soc Mass Spectrom. 2004 Nov;15(11):1545-55
pubmed: 15519221
FEBS Lett. 2004 May 21;566(1-3):270-4
pubmed: 15147907
mBio. 2019 Jul 2;10(4):
pubmed: 31266872
Sci Transl Med. 2019 Jul 17;11(501):
pubmed: 31316007
J Virol. 2012 Nov;86(22):12039-52
pubmed: 22933282
Lancet. 2008 Nov 29;372(9653):1881-1893
pubmed: 19012954
Nature. 2014 Oct 30;514(7524):642-5
pubmed: 25119033
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1739-1744
pubmed: 30642966
Elife. 2018 Nov 09;7:
pubmed: 30412051
Nature. 2003 Mar 20;422(6929):307-12
pubmed: 12646921
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
Immunity. 2019 Jan 15;50(1):241-252.e6
pubmed: 30552025
J Virol. 2005 Dec;79(24):15547-55
pubmed: 16306625
PLoS One. 2012;7(7):e42209
pubmed: 22848744
Science. 1999 Apr 30;284(5415):816-9
pubmed: 10221916
Lancet Infect Dis. 2011 Jul;11(7):507-15
pubmed: 21570355
Virology. 2015 Jan 15;475:37-45
pubmed: 25462344
Cell Rep. 2018 Aug 21;24(8):1958-1966.e5
pubmed: 30134158
J Exp Med. 2014 Sep 22;211(10):2061-74
pubmed: 25155019
N Engl J Med. 2021 Mar 18;384(11):1003-1014
pubmed: 33730454
Cell Rep. 2019 May 21;27(8):2426-2441.e6
pubmed: 31116986
PLoS Pathog. 2016 Dec 13;12(12):e1006104
pubmed: 27959961
PLoS Pathog. 2013 Oct;9(10):e1003738
pubmed: 24204277
Nat Med. 1998 Jun;4(6):679-84
pubmed: 9623976
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Sci Adv. 2021 Jul 28;7(31):
pubmed: 34321200
J Virol. 2010 Oct;84(20):10510-21
pubmed: 20686044
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
Immunity. 2018 Aug 21;49(2):288-300.e8
pubmed: 30097292
Nat Med. 2008 Jun;14(6):617-21
pubmed: 18535579
Cell. 2019 May 16;177(5):1153-1171.e28
pubmed: 31080066
Sci Transl Med. 2019 Jul 24;11(502):
pubmed: 31341061
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28014-28025
pubmed: 33093196
Science. 1992 Dec 18;258(5090):1938-41
pubmed: 1470917
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
PLoS Pathog. 2013;9(11):e1003754
pubmed: 24278016
Cell Rep. 2020 Sep 8;32(10):108122
pubmed: 32905766

Auteurs

Fangzhu Zhao (F)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Zachary T Berndsen (ZT)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

Nuria Pedreño-Lopez (N)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Alison Burns (A)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Joel D Allen (JD)

School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK.

Shawn Barman (S)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Wen-Hsin Lee (WH)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

Srirupa Chakraborty (S)

Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 87545, USA.

Sandrasegaram Gnanakaran (S)

Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 87545, USA.

Leigh M Sewall (LM)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

Gabriel Ozorowski (G)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.

Oliver Limbo (O)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI, New York, NY, 10004, USA.

Ge Song (G)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Peter Yong (P)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Sean Callaghan (S)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Jessica Coppola (J)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Kim L Weisgrau (KL)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, 53715, USA.

Jeffrey D Lifson (JD)

AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, 21701, USA.

Rebecca Nedellec (R)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA.

Thomas B Voigt (TB)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Fernanda Laurino (F)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Johan Louw (J)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Brandon C Rosen (BC)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.
Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.

Michael Ricciardi (M)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Max Crispin (M)

School of Biological Sciences, University of Southampton, Southampton, SO17 1BJ, UK.

Ronald C Desrosiers (RC)

Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.

Eva G Rakasz (EG)

Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, 53715, USA.

David I Watkins (DI)

Department of Pathology, George Washington University, Washington, DC, 20037, USA.

Raiees Andrabi (R)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrabi@scripps.edu.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrabi@scripps.edu.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. andrabi@scripps.edu.

Andrew B Ward (AB)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA. andrew@scripps.edu.

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA. burton@scripps.edu.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA. burton@scripps.edu.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. burton@scripps.edu.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, 02139, USA. burton@scripps.edu.

Devin Sok (D)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, 92037, USA. dsok@iavi.org.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, 92037, USA. dsok@iavi.org.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, 92037, USA. dsok@iavi.org.
IAVI, New York, NY, 10004, USA. dsok@iavi.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH